Piperacillin pharmacokinetics in pediatric patients

Area of Science:

• Pharmacology
• Pediatric Medicine
• Antibiotic Pharmacokinetics

Background:

• Piperacillin is a widely used antibiotic.
• Understanding its pharmacokinetic profile in pediatric populations is crucial for effective treatment.
• Variations in renal function can significantly impact drug clearance.

Purpose of the Study:

• To characterize the pharmacokinetics of piperacillin in pediatric patients.
• To determine appropriate piperacillin dosing regimens for children, considering renal function.
• To investigate the extent of nonrenal elimination of piperacillin in this age group.

Main Methods:

• Pharmacokinetic analysis of piperacillin serum concentrations in 15 pediatric patients.
• Dosage administered: 1.5 +/- 0.4 g/m2 every 4-6 hours.
• Evaluation of elimination half-life and clearance in patients with normal and impaired renal function.

Main Results:

• Mean elimination half-life in pediatric patients was 37.0 +/- 13.3 minutes.
• Patients with renal impairment showed a longer mean half-life of 60.1 +/- 12.4 minutes.
• A significant nonrenal elimination pathway for piperacillin was identified (renal clearance to total clearance ratio of 0.57).

Conclusions:

• Piperacillin exhibits a shorter elimination half-life in children compared to adults.
• Recommended dosage for children with normal renal function is 1.5 g/m2 every 4 hours via 30-min infusion.
• A formula is provided to adjust piperacillin dosage for pediatric patients with renal impairment based on creatinine clearance.